Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.

S'inscrire

GALT Galectin Therapeutics Inc

1,95

0,00 (0,00%)

Avant marché

Dernière mise à jour : 10:00:00

Retardé de 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

10/04/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Dominick Iadicicco, as a duly authorized representative of STIFEL, as attorney-in-fact for Pol Boudes

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Galectin Therapeutics (NASDAQ:GALT)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024

Plus de graphiques de la Bourse Galectin Therapeutics

Galectin Therapeutics (NASDAQ:GALT)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024

Plus de graphiques de la Bourse Galectin Therapeutics

Actualités Galectin Therapeutics Inc

Form ARS - Annual Report to Security Holders
Mardi 3 Décembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mardi 3 Décembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form DEF 14A - Other definitive proxy statements
Mardi 3 Décembre 2024 ( il y a 1 semaine) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 14 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 8-K - Current report
Jeudi 14 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jeudi 14 Novembre 2024 ( il y a 4 semaines) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 23 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Jeudi 17 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mercredi 16 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Vendredi 4 Octobre 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Lundi 9 Septembre 2024 ( il y a 3 mois) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Lundi 26 Août 2024 ( il y a 4 mois) • Edgar (US Regulatory)

Plus d'articles sur Galectin Therapeutics Inc

Lvmh Moet Hennessy Louis...

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales